Medisch Spectrum Twente

Az itteni vizsgálatok

Miről szól a helyszín 132 vizsgálata, a regiszteri adatlapjaik szerint.

Betegségek

• Koszorúér-betegség14 vizsgálat
• Szívelégtelenség13 vizsgálat
• Stroke (szélütés)9 vizsgálat
• Tüdőrák8 vizsgálat
• Vastagbélrák8 vizsgálat
• Akut mieloid leukémia (AML)7 vizsgálat
• Aortic aneurysm7 vizsgálat
• Melanóma6 vizsgálat
• Rheumatoid arthritis6 vizsgálat
• Gyermekkori daganatok5 vizsgálat
• Hasnyálmirigyrák5 vizsgálat
• Mielodiszplasztikus szindróma (MDS)5 vizsgálat
• és még 37

Fázis

• 3. fázis61 vizsgálat
• 4. fázis20 vizsgálat
• 2. fázis13 vizsgálat
• 2/3. fázis1 vizsgálat

Állapot

• Toboroz48 vizsgálat
• Fut, nem toboroz39 vizsgálat
• Lezárult26 vizsgálat
• Még nem toboroz12 vizsgálat
• Meghívásos bevonás4 vizsgálat
• Leállították2 vizsgálat
• Felfüggesztve1 vizsgálat

Fő szponzor

• Medisch Spectrum Twente9 vizsgálat
• Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)7 vizsgálat
• Stichting Hemato-Oncologie voor Volwassenen Nederland7 vizsgálat
• Radboud University Medical Center6 vizsgálat
• GlaxoSmithKline5 vizsgálat
• és még 68

Futó vizsgálatok

• Még nem toboroz

  Alert-HF: Early Detection and Intervention on Atrial Fibrillation in Heart Failure Patients

  NCT07816458· Medisch Spectrum Twente· Forrás

  Contact: Dr Schuuring, MD PhD

• Toboroz

  A Clinical Trial To Investigate The Effect Of EA-230 On Hospital Length Of Stay In Patients With Coronary Artery Disease (CAD) Undergoing Coronary Artery Bypass Grafting (CABG) Surgery.

  NCT07357675· 3. fázis· EBI Anti Sepsis BV· Forrás

  Contact: Bas Ossenkoppele, Msc

• Még nem toboroz

  A Research Study to Look at How Well Zenagamtide Works Compared to Placebo in People With Established Atherosclerotic Cardiovascular Disease and Either Overweight or Obesity

  NCT07861100· 3. fázis· Novo Nordisk A/S· Forrás

• Toboroz

  An International, Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase III Trial on the Effects of EA-230 on the Length of Hospital Stay Following On-Pump Coronary Artery Bypass Grafting Surgery

  2025-525053-39-00· 3. fázis· EBI Anti Sepsis B.V.· Forrás

• Fut, nem toboroz

  Investigating the Impact of Nudging Cardiologists to Prescribe Class I Recommendations Foundational- and Additional Medical Therapy in Heart Failure Patients

  NCT06844006· Medisch Spectrum Twente· Forrás

• Még nem toboroz

  Tapering optimisation with placebo-based mechanisms in rheumatoid arthritis: the TOP-RA trial

  2025-524593-42-00· 4. fázis· Universiteit Leiden· Forrás

• Még nem toboroz

  Skin-in-Sight: a Longitudinal Cohort Infrastructure for Standardized Remote Monitoring and the Evaluation of Digital Care Innovations in Chronic Skin Diseases

  NCT07804134· Medisch Spectrum Twente· Forrás

  Contact: Bram de Kinderen, MSc

• Még nem toboroz

  A Phase 2, randomized, double-blind, placebo-controlled trial to evaluate the efficacy, safety, and tolerability of CRD-4730 in patients with heart failure with reduced ejection fraction (HFREF) (CALIBRATE-HF)

  2025-525033-31-00· 2. fázis· Cardurion Pharmaceuticals Inc.· Forrás

• Toboroz

  HO182 CLL: Treatment of patients with chronic lymphocytic leukemia (CLL) with 6 cycles of rituximab in combination with 6 or 26 cycles of venetoclax upon recurrence of the disease after previous treatment

  2025-524283-38-00· 3. fázis· Hemato-Oncologie voor Volwassenen Nederland (Hovon) Stichting· Forrás

• Toboroz

  Methotrexate in paediatric and adolescent Crohn’s disease: an observational study

  2025-524129-42-00· 4. fázis· Amsterdam UMC Stichting· Forrás

• Meghívásos bevonás

  Explainable AI for Predicting Hospital Admissions in Heart Failure: ExplAIn-HF

  NCT07689760· Medisch Spectrum Twente· Forrás

• Toboroz

  PROTECx - Pembrolizumab Registry for Outcomes and Treatment Evaluation in Cervical Cancer

  2025-522883-34-00· 4. fázis· Universitair Medisch Centrum Groningen· Forrás

• Toboroz

  Pembrolizumab Registry for Outcomes and Treatment Evaluation in Cervical Cancer

  NCT07645625· 4. fázis· University Medical Center Groningen· Forrás

  Contact: A. N.M. Wymenga

• Még nem toboroz

  SVF-Treo Study: Influence of Cardiac and Respiratory Pulsatility Deformation

  NCT07475260· University of Twente· Forrás

  Contact: Robert H Geelkerken

• Még nem toboroz

  Pembrolizumab Adjuvant in Patients With Early-stage Triple Negative Breast Cancer With Residual Disease After Neoadjuvant Pembrolizumab Plus Chemotherapy

  NCT07486687· 3. fázis· The Netherlands Cancer Institute· Forrás

• Fut, nem toboroz

  Pulmonary function and sleep related disorders during cervical admission of intrathecal baclofen in spinal cord injury; a safety study

  2023-508143-51-01· 4. fázis· Roessingh Centrum Voor Revalidatie· Forrás

• Toboroz

  Study for Frail Patients With Newly Diagnosed Multiple Myeloma Treated With Daratumumab With Teclistamab or Talquetamab.

  NCT07107529· 2. fázis· European Myeloma Network B.V.· Forrás

• Toboroz

  A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-1)

  NCT07276724· 3. fázis· Generate Biomedicines· Forrás

• Toboroz

  NO Re-excision MelanomA - NORMA 2

  NCT07530887· 3. fázis· Marieke Goodijk· Forrás

  Contact: A.E. (Anneriet) Dassen

• Toboroz

  eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation

  NCT07177339· 3. fázis· GlaxoSmithKline· Forrás

• Toboroz

  Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity (MARITIME-HF)

  2024-516654-22-00· 3. fázis· Amgen Inc.· Forrás

• Toboroz

  REDO-JAK: Dose Reduction of Janus Kinase Inhibitors in Patients With Inflammatory Rheumatic Diseases

  NCT07160231· 4. fázis· Sint Maartenskliniek· Forrás

• Toboroz

  Preventing postoperative complications in patients undergoing high-risk pancreatoduodenectomy with a bundle approach including hydrocortisone, ocreotide, and teres ligament patch (PANENCA): an international randomized controlled multicenter trial

  2024-519667-18-00· 4. fázis· Amsterdam UMC Stichting· Forrás

• Toboroz

  Prospective Data Collection Initiative on Thoracic Malignancies

  NCT06996249· Dutch Society of Physicians for Pulmonology and Tuberculosis· Forrás

  Contact: F.T.A. van der Velde

• Toboroz

  A study to investigate the effect of adding venetoclax to treatment with ivosidenib and azacitidine in patients with acute myeloid leukemia (AML) with a specific gene abnormality who have not previously been treated and who are not eligible for intensive chemotherapy.

  2024-512753-24-00· 3. fázis· Hemato-Oncologie voor Volwassenen Nederland (Hovon) Stichting· Forrás

• Toboroz

  Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity

  NCT07037459· 3. fázis· Amgen· Forrás

• Toboroz

  Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation

  NCT06959095· 3. fázis· GlaxoSmithKline· Forrás

• Toboroz

  Revumenib in Combination With Azacitidine + Venetoclax in Patients NPM1-mutated or KMT2A-rearranged AML

  NCT06652438· 3. fázis· Stichting Hemato-Oncologie voor Volwassenen Nederland· Forrás

• Toboroz

  StAtins in Frail oldEr patients with ischemic Stroke or Transient ischemic attack – The Randomized Controlled Trial

  2024-517343-31-00· 4. fázis· Amsterdam UMC Stichting· Forrás

• Toboroz

  Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin

  NCT06677060· 3. fázis· AstraZeneca· Forrás

• Toboroz

  Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Subjects With Metastatic Colorectal Cancer With KRAS p.G12C Mutation (CodeBreaK 301)

  2022-502352-31-00· 3. fázis· Amgen Inc.· Forrás

• Fut, nem toboroz

  Study to Assess the Efficacy of Rina-S Compared to Treatment of Investigator's Choice in Participants With Platinum Resistant Ovarian Cancer

  NCT06619236· 3. fázis· Genmab· Forrás

• Még nem toboroz

  Filgotinib bridging in newly diagnosed rheumatoid arthritis patients (FAST RA trial); A pragmatic randomized controlled non-inferiority low intervention clinical trial

  2024-517112-30-00· 4. fázis· Medisch Spectrum Twente· Forrás

• Toboroz

  Safe Stop Trial Melanoma

  2024-516937-10-01· 3. fázis· Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)· Forrás

• Toboroz

  Stopping or continuing blood thinners after stroke at young age without a known cause: STOP trial

  2024-513092-40-00· 4. fázis· Stichting Radboud universitair medisch centrum· Forrás

• Toboroz

  The PREDMETH trial: Effectiveness of methotrexate versus prednisone as first-line therapy for pulmonary sarcoidosis – A randomized controlled trial

  2024-514055-15-00· 4. fázis· Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)· Forrás

• Toboroz

  Timing of start of systemlc treatment for asymptomatic MEtastasized PANcreatic cancer (TIMEPAN): a prospective multicenter patient preference cohort

  NCT04897854· 3. fázis· Amsterdam UMC· Forrás

• Fut, nem toboroz

  Safe Stop ipi-nivo

  2024-516938-34-00· 3. fázis· Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)· Forrás

• Fut, nem toboroz

  Dose tapering and Early Discontinuation to InCreAse cosT-effictIveness Of immunotherapy for Non-small cell lung carcinoma trial number 1 (NVALT-30 - Dedication-1)

  NCT04909684· 3. fázis· Stichting Radboud universitair medisch centrum· Forrás

• Toboroz

  Preoperative Optimisation of Modifiable Risk Factors in Surgery of the Pancreas

  NCT05851534· Maastricht University Medical Center· Forrás

  Contact: Daan Lips, MD PhD

• Meghívásos bevonás

  EMDR for Persistent Pain in RA

  NCT05941559· Medisch Spectrum Twente· Forrás

• Még nem toboroz

  FET-PET-Guided Management of Pseudoprogression in Glioblastoma

  NCT06480721· Veerle Ruijters· Forrás

  Contact: Veerle J Ruijters, MD

• Toboroz

  Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Participants With Metastatic Colorectal Cancer With KRAS p.G12C Mutation

  NCT06252649· 3. fázis· Amgen· Forrás

• Toboroz

  DOSAGE Study: Upfront Dose-Reduced Chemotherapy in Older Patients with Metastatic Colorectal Cancer

  NCT06275958· 3. fázis· Leiden University Medical Center· Forrás

• Toboroz

  FeAsiBility of a Treatment Free Interval in Newly Diagnosed MM Patients Treated With Daratumumab-lenalidomide-dexamethasone (HOVON174MM)

  NCT06187441· 3. fázis· Stichting Hemato-Oncologie voor Volwassenen Nederland· Forrás

• Fut, nem toboroz

  The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-Outcomes)

  NCT06383390· 3. fázis· Eli Lilly and Company· Forrás

• Toboroz

  Cohort Multiple Randomized Controlled Trial in Pediatric Asthma

  NCT06278662· Mattienne van der Kamp· Forrás

  Contact: Job van der Palen, Full professor

• Toboroz

  Study on Efficacy and Safety of Givinostat Versus Hydroxyurea in Patients With Polycythemia Vera

  NCT06093672· 3. fázis· Italfarmaco· Forrás

• Toboroz

  The Beneficial Value of PET/CT in the Follow-up of Stage III Non-small Cell Lung Cancer Patients

  NCT06082492· Radboud University Medical Center· Forrás

  Contact: Onderzoeksbureau Longgeneeskunde

• Toboroz

  Apa/Enza-short Study: Shorter Treatment With Androgen Receptor Pathway Inhibitor in Patients With Low-volume Metastatic Castration-sensitive Prostate Cancer

  NCT07260435· 3. fázis· Nick Beije· Forrás

  Contact: Dr. A.N.M. Wymenga

Showing 50 of 103.

Egyszerre toboroz

Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.

• Szívelégtelenség7 toboroz
• Koszorúér-betegség6 toboroz
• Vastagbélrák6 toboroz
• Rheumatoid arthritis4 toboroz
• Stroke (szélütés)4 toboroz
• Akut mieloid leukémia (AML)3 toboroz
• Aortic aneurysm3 toboroz
• Asztma3 toboroz
• Elhízás3 toboroz
• Hasnyálmirigyrák3 toboroz
• Tüdőrák3 toboroz
• Hólyagrák2 toboroz
• Krónikus obstruktív tüdőbetegség (COPD)2 toboroz
• Méhnyakrák2 toboroz
• Melanóma2 toboroz
• Mielóma multiplex2 toboroz
• Petefészekrák2 toboroz
• Pikkelysömör2 toboroz
• Pitvarfibrilláció2 toboroz
• Prosztatarák2 toboroz
• Arthritis psoriatica1 toboroz
• Atópiás dermatitisz (ekcéma)1 toboroz
• Coeliac disease1 toboroz
• Crohn-betegség1 toboroz
• Glioblasztóma1 toboroz
• Gyermekkori daganatok1 toboroz
• Hidradenitis suppurativa1 toboroz
• Krónikus limfoid leukémia (CLL)1 toboroz
• Méhtestrák1 toboroz
• Mezotelióma1 toboroz
• Mielodiszplasztikus szindróma (MDS)1 toboroz
• Sarcoidosis1 toboroz
• Spondylitis ankylopoetica (Bechterew-kór)1 toboroz
• Tripla negatív emlőrák1 toboroz

Lezárt vizsgálatok

• Lezárult

  Study of the Effectiveness and Safety of Acasunlimab Alone or With Pembrolizumab in treating Advanced Melanoma of the Skin That Has Returned After or did not respond to Cancer Immunotherapy (ABBIL1TY MELANOMA-07)

  NCT06984328· 2. fázis· Genmab A/S· Forrás

• Lezárult

  GENPAD

  NCT04619927· 4. fázis· Radboud universitair medisch centrum Stichting· Forrás

• Fut, nem toboroz

  Nipocalimab in Moderate to Severe Sjogren's Disease

  NCT06741969· 3. fázis· Janssen Research & Development, LLC· Forrás

• Lezárult

  Multicentre Randomized trial of Ghrelin in anterior circulation ischemic stroke treated with endovascular thrombectomy. A randomized phase 2 trial.

  NCT05726240· 2. fázis· Rijnstate Ziekenhuis Stichting· Forrás

• Lezárult

  THE (COST)EFFECTIVENESS OF NEOADJUVANT FOLFIRINOX VERSUS NEOADJUVANT GEMCITABINE BASED CHEMORADIOTHERAPY AND ADJUVANT GEMCITABINE FOR (BORDERLINE) RESECTABLE PANCREATIC CANCER (PREOPANC-2 STUDY)

  2024-516260-29-00· 3. fázis· Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)· Forrás

• Lezárult

  Comparing the effectiveness of our tailor-made management approach with routine care from a clinical, patient's as well as an economic point of view. Tailoring of treatment is done by taking the presence of autoantibodies and the quick response to glucocorticoids and JAK inhibitors into account.

  2024-511530-12-01· 4. fázis· Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)· Forrás

• Fut, nem toboroz

  A Phase 3 study of belrestotug plus dostarlimab compared with placebo plus pembrolizumab in previously untreated PD L1 high NSCLC

  2023-504753-12-00· 3. fázis· Glaxosmithkline Research & Development Limited· Forrás

• Lezárult

  A Phase IIb Study of AZD5462 in Patients With Chronic Heart Failure

  NCT06299826· 2. fázis· AstraZeneca· Forrás

• Lezárult

  A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome

  NCT05754957· 3. fázis· Janssen Research & Development, LLC· Forrás

• Fut, nem toboroz

  A Study Evaluating the Effect of Filgotinib in Participants With Active Axial Spondyloarthritis

  NCT05785611· 3. fázis· Alfasigma S.p.A.· Forrás

• Lezárult

  A study to learn how well the study treatment asundexian works and how safe it is compared to apixaban to prevent stroke or systemic embolism in people with irregular and often rapid heartbeat (atrial fibrillation), and at risk for stroke

  NCT05643573· 3. fázis· Bayer AG· Forrás

• Lezárult

  REal-time Data Monitoring for Shared Adaptive, Multi-domain and Personalised Prediction and Decision Making for Long-term Pulmonary Care Ecosystems (RE-SAMPLE)

  NCT04955080· Medisch Spectrum Twente· Forrás

• Lezárult

  A Study of GSK3511294 (Depemokimab) Compared With Mepolizumab or Benralizumab in Participants With Severe Asthma With an Eosinophilic Phenotype

  NCT04718389· 3. fázis· GlaxoSmithKline· Forrás

• Lezárult

  EMPACT-MI: A Study to Test Whether Empagliflozin Can Lower the Risk of Heart Failure and Death in People Who Had a Heart Attack (Myocardial Infarction)

  NCT04509674· 3. fázis· Boehringer Ingelheim· Forrás

• Lezárult

  Placebo-controlled Study Comparing Niraparib Plus Pembrolizumab Versus Placebo Plus Pembrolizumab as Maintenance Therapy in Participants With Advanced/Metastatic Non-Small Cell Lung Cancer

  NCT04475939· 3. fázis· GlaxoSmithKline· Forrás

• Leállították

  ACT Guided Heparinization During Open Abdominal Aortic Aneurysm Repair.

  NCT04061798· 4. fázis· Dijklander Ziekenhuis· Forrás

• Lezárult

  Morphine or Fentanyl for Refractory Dyspnea in COPD

  NCT03834363· 4. fázis· Huib A.M. Kerstjens· Forrás

• Lezárult

  Effect of Evolocumab in Patients at High Cardiovascular Risk Without Prior Myocardial Infarction or Stroke

  NCT03872401· 3. fázis· Amgen· Forrás

• Lezárult

  TOFA-PREDICT

  2024-510903-12-00· 4. fázis· Universitair Medisch Centrum Utrecht· Forrás

• Leállították

  Assessment of the WATCHMAN™ Device in Patients Unsuitable for Oral Anticoagulation

  NCT02928497· Boston Scientific Corporation· Forrás

• Lezárult

  Standard Chemoimmunotherapy (FCR/BR) Versus Rituximab + Venetoclax (RVe) Versus Obinutuzumab (GA101) + Venetoclax (GVe) Versus Obinutuzumab + Ibrutinib + Venetoclax (GIVe) in Fit Patients With Previously Untreated Chronic Lymphocytic Leukemia (CLL) Without Del(17p) or TP53 Mutation

  NCT02950051· 3. fázis· German CLL Study Group· Forrás

• Lezárult

  GIVE trial (Gazyvaro In combination with VEnetoclax in Elderly CLL)

  2024-511048-22-00· 2. fázis· Hemato-Oncologie voor Volwassenen Nederland (Hovon) Stichting· Forrás

• Lezárult

  autologous Transplantation after a Rituximab/Ibrutinib/Ara-c containing iNduction in Generalized mantle cell Lymphoma – a randomized European MCL Network trial

  2024-511235-10-00· 3. fázis· Klinikum der Universitaet Muenchen AöR· Forrás

• Lezárult

  Top-down Infliximab Study in Kids With Crohn's Disease

  NCT02517684· 4. fázis· Erasmus Medical Center· Forrás

• Lezárult

  Treatment Strategies in Colorectal Cancer Patients With Initially Unresectable Liver-only Metastases

  NCT02162563· 3. fázis· Dutch Colorectal Cancer Group· Forrás

• Lezárult

  R-CHOP + R-HAD vs R-CHOP Followed by Maintenance Lenalidomide + Rituximab vs Rituximab for Older Patients With MCL

  NCT01865110· 3. fázis· The Lymphoma Academic Research Organisation· Forrás

• Lezárult

  Study Comparing Combination of LGX818 Plus MEK162 Versus Vemurafenib and LGX818 Monotherapy in BRAF Mutant Melanoma

  NCT01909453· 3. fázis· Pfizer· Forrás

• Lezárult

  ANCHOR (Aneurysm Treatment Using the Heli-FX™ EndoAnchor™ System Global Registry)

  NCT01534819· Medtronic Cardiovascular· Forrás